Mayo Stephen
SEC Form 4 insider trading activity
Mayo Stephen has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 6, 2026.
On the most recent filing, Mayo Stephen is listed as Director at Sarepta Therapeutics, Inc. Inside the rolling window, Mayo Stephen reported no open-market purchases and 1 open-market sale totaling $123K in SRPT.
Companies traded
Other insiders at SRPT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$123K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Mayo Stephen made?
Mayo Stephen has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Mayo Stephen trade?
Mayo Stephen has filed SEC Form 4 disclosures for 1 company, including SRPT.
When was Mayo Stephen's most recent SEC Form 4 filing?
Mayo Stephen's most recent SEC Form 4 filing on Tracefour is dated Jun 6, 2026.
What is Mayo Stephen's total buy and sell value in the current window?
Inside the rolling retention window, Mayo Stephen bought $0 and sold $123K based on SEC Form 4 filings.
What was Mayo Stephen's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,239 SRPT shares on 2026-03-12, worth $123K, per SEC Form 4 filings.